Concepedia

Michael P. Dubé

MP

Statistics

Publications

62

Citations

3.6K

H-Index

34

Active since

1992

Affiliations

University of Southern California(Current)

University of California San Diego

University of Wisconsin–Madison

Harbor–UCLA Medical Center

Johns Hopkins University

Michael P. Dubé is an author at University of Southern California specializing in antiretroviral therapy, infectious diseases, and antiviral therapy.

ORCID

Publications per year

1992–2024

62

Publications

62

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

Richard Haubrich, Susan J. Little, Judith S. Currier et al. · AIDS · 1999 · 551 citations

, , +16

Prophylaxis against Disseminated<i>Mycobacterium avium</i>Complex with Weekly Azithromycin, Daily Rifabutin, or Both

Diane V. Havlir, Michael P. Dubé, Fred R. Sattler et al. · New England Journal of Medicine · 1996 · 333 citations · Full text

, , +16

Tuberculous meningitis in patients with and without human immunodeficiency virus infection

Michael P. Dubé, Paul Holtom, Robert A. Larsen · The American Journal of Medicine · 1992 · 169 citations

, , +7

Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s

Grace A. McComsey, Carlee Moser, Judith S. Currier et al. · Clinical Infectious Diseases · 2016 · 164 citations · Full text

, , +17

Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir

Todd T. Brown, Carlee Moser, Judith S. Currier et al. · The Journal of Infectious Diseases · 2015 · 120 citations · Full text

, , +17

1–5 of 62